Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 9, 2019
miRagen Announces First Quarter 2019 Financial Results and Provides Corporate Update
BOULDER, Colo., May 08, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on ...
May 9, 2019
Zogenix Provides Corporate Update and Reports First Quarter 2019 Financial Results
EMERYVILLE, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, today announced financial results for the ...
May 9, 2019
Paratek’s NUZYRA™ (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market
BOSTON, May 08, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today ...
May 9, 2019
CymaBay Reports First Quarter 2019 Financial Results and Provides Corporate Update
NEWARK, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
May 9, 2019
electroCore to Announce First Quarter 2019 Financial Results on Tuesday, May 14
BASKING RIDGE, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, announced that it will report first quarter ended ...
May 9, 2019
ADMA Biologics Reports First Quarter 2019 Financial Results
RAMSEY, N.J. and BOCA RATON, Fla., May 08, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
May 9, 2019
Inspire Medical Systems, Inc. to Present at the 2019 RBC Capital Markets Global Healthcare Conference
MINNEAPOLIS, May 08, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative ...
May 9, 2019
Aileron Therapeutics Reports First Quarter 2019 Financial Results
WATERTOWN, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stabilized cell-permeating peptides to treat cancer and ...
May 9, 2019
Prometic strengthens its leadership with a new management structure and the appointment of three new directors
LAVAL , QC and CAMBRIDGE, United Kingdom , May 8, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic" or "Corporation") is pleased to announce today ...
May 9, 2019
Prometic reports its 2019 first quarter financial results
LAVAL, QC , May 8, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic" or the "Corporation") reported today its unaudited financial results for the ...
May 9, 2019
Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights
MONT-SAINT-GUIBERT, Belgium, May 09, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
May 9, 2019
Reata Pharmaceuticals, Inc. Announces First Quarter 2019 Financial Results and an Update on Development Programs
IRVING, Texas, May 09, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended ...
May 9, 2019
Tyme Technologies to Participate at the Oppenheimer Oncology Insight Summit on May 16th
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will ...
May 9, 2019
Bellerophon Provides Business Update and Reports First Quarter 2019 Financial Results
WARREN, N.J., May 09, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update ...
May 7, 2019
Foamix Reports First Quarter 2019 Financial Results and Provides Corporate Update
REHOVOT, Israel and BRIDGEWATER, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical ...
May 7, 2019
Allakos Announces Positive Results with AK002 in Patients with Severe Allergic Conjunctivitis
REDWOOD CITY, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell ...
May 7, 2019
Novelion Therapeutics Reports First Quarter 2019 Financial Results
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies ...
May 7, 2019
Aptose Reports Results for the First Quarter Ended March 31, 2019
SAN DIEGO and TORONTO, May 07, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing ...
May 7, 2019
CohBar Reports First Quarter 2019 Financial Results and Business Update
MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related ...
May 7, 2019
Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update
DUBLIN, Ireland, May 07, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage neuroscience company, today reported financial results for the first quarter of ...
Page 28 of 169